MPPE1 and cancer: In this setting, the cDC1-dependent regression of orthotopic lung cancers and fibrosarcomas by pharmacological BCL2 inhibitors such as venetoclax and navitoclax was independent of cancer cell-intrinsic mechanisms, based on two sets of observations.